Harte-Hanks EBIT

As of the most recent data (June 2026), HHS shows a EBIT of $-5.6M. That compares with $-60M in the prior-year period — up 90.7% year over year. That is below the Consumer Discretionary sector average of $150B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HHS's EBIT is now $-5.6M (was $-60M) — a 90.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Harte-Hanks is outperforming or lagging.

The Consumer Discretionary sector average EBIT is about $150B. Harte-Hanks is at $-5.6M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how HHS stacks up against individual peers as well.

Tracking HHS's ebit over time shows whether Harte-Hanks is scaling, shrinking, or reshaping that part of the business. The current reading is $-5.6M That compares with $-60M in the prior-year period — up 90.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Harte-Hanks's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-5.6M) with ownership activity and broader fundamentals.